Hodgkin Lymphoma Update - InterLymph 2017

Ruth Jarrett, Professor of Molecular Pathology, Institute of Infection, Immunity & Inflammation, University of Glasgow, Scotland

InterLymph Hodgkin Lymphoma Working Group

The InterLymph Consortium ( International Consortium of Investigators Working on Lymphoma Epidemiologic Studies) is an international group of scientists who undertake research projects and pool data across studies to better understand lymphoma risk factors. https://epi.grants.cancer.gov/InterLymph

Visit http://www.lymphomacoalition.org to get up to date facts and statistics about lymphoma.

Links to publications:
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. http://onlinelibrary.wiley.com..../doi/10.1002/(SICI)1

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. http://www.bloodjournal.org/co....ntent/106/7/2444.sho

A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma. http://cebp.aacrjournals.org/c....ontent/24/12/1838.sh

The Role of Viruses in the Genesis of Hodgkin Lymphoma. https://link.springer.com/chap....ter/10.1007/978-3-31

The Chemokine CCL17/TARC as a biomarker in Hodgkin lymphoma. http://emjreviews.com/wp-conte....nt/uploads/EMJ-Hemat

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma. http://onlinelibrary.wiley.com..../doi/10.1002/ajh.233